chrX-38054388-G-C
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4BP6BS2
The NM_138780.3(SYTL5):āc.295G>Cā(p.Gly99Arg) variant causes a missense change. The variant allele was found at a frequency of 0.0000967 in 1,209,416 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 34 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: š 0.000099 ( 0 hom., 2 hem., cov: 22)
Exomes š: 0.000097 ( 0 hom. 32 hem. )
Consequence
SYTL5
NM_138780.3 missense
NM_138780.3 missense
Scores
2
7
8
Clinical Significance
Conservation
PhyloP100: 3.64
Genes affected
SYTL5 (HGNC:15589): (synaptotagmin like 5) The protein encoded by this gene belongs to the synaptotagmin-like (Slp) protein family, which contains a unique homology domain at the N-terminus, referred to as the Slp homology domain (SHD). The SHD functions as a binding site for Rab27A, which plays a role in protein transport. Expression of this gene is restricted to placenta and liver, suggesting that it might be involved in Rab27A-dependent membrane trafficking in specific tissues. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.29250368).
BP6
Variant X-38054388-G-C is Benign according to our data. Variant chrX-38054388-G-C is described in ClinVar as [Conflicting_classifications_of_pathogenicity]. Clinvar id is 2378747.We mark this variant Likely_benign, oryginal submissions are: {Likely_benign=1, Uncertain_significance=1}. Variant chrX-38054388-G-C is described in Lovd as [Likely_benign].
BS2
High Hemizygotes in GnomAd4 at 2 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SYTL5 | NM_138780.3 | c.295G>C | p.Gly99Arg | missense_variant | 3/17 | ENST00000297875.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SYTL5 | ENST00000297875.7 | c.295G>C | p.Gly99Arg | missense_variant | 3/17 | 5 | NM_138780.3 | P4 | |
SYTL5 | ENST00000456733.2 | c.295G>C | p.Gly99Arg | missense_variant | 2/17 | 1 | A1 |
Frequencies
GnomAD3 genomes AF: 0.0000987 AC: 11AN: 111395Hom.: 0 Cov.: 22 AF XY: 0.0000595 AC XY: 2AN XY: 33593
GnomAD3 genomes
AF:
AC:
11
AN:
111395
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33593
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000104 AC: 19AN: 182653Hom.: 0 AF XY: 0.0000742 AC XY: 5AN XY: 67355
GnomAD3 exomes
AF:
AC:
19
AN:
182653
Hom.:
AF XY:
AC XY:
5
AN XY:
67355
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000965 AC: 106AN: 1098021Hom.: 0 Cov.: 31 AF XY: 0.0000881 AC XY: 32AN XY: 363401
GnomAD4 exome
AF:
AC:
106
AN:
1098021
Hom.:
Cov.:
31
AF XY:
AC XY:
32
AN XY:
363401
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000987 AC: 11AN: 111395Hom.: 0 Cov.: 22 AF XY: 0.0000595 AC XY: 2AN XY: 33593
GnomAD4 genome
AF:
AC:
11
AN:
111395
Hom.:
Cov.:
22
AF XY:
AC XY:
2
AN XY:
33593
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:1Benign:1
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 10, 2022 | The c.295G>C (p.G99R) alteration is located in exon 3 (coding exon 2) of the SYTL5 gene. This alteration results from a G to C substitution at nucleotide position 295, causing the glycine (G) at amino acid position 99 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Mar 01, 2023 | SYTL5: BS2 - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Pathogenic
DEOGEN2
Benign
T;.
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Uncertain
D
MetaRNN
Benign
T;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
N;N;N
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Benign
T;T
Polyphen
P;.
Vest4
MVP
MPC
0.15
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at